Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Intuitive Machines Announces Key Leadership Appointments
-
Kvika banki hf.: Transaction in relation to a share buyback programme
-
Alliance Trust PLC - Net Asset Value
-
Medicenna Presents Preclinical Results from its IL-2 Super-Antagonist and Anti-PD1-IL-2 BiSKIT Programs at The Promise of Interleukin-2 Therapy Conference
-
Progress Software to Report Third Quarter 2024 Financial Results on September 24, 2024
-
TGS: MANDATORY NOTIFICATION OF TRADES
-
Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of the Bank of America Securities 2024 Global Real Estate Conference
-
Record date is determined for South Bow spinoff
-
Itafos Announces Amendment and Extension of Its Existing Credit Facilities
-
Revival Gold Reports Positive Metallurgical Tests Results at Mercur
-
First Trust Introduces a Small and Mid Cap Dividend Achievers ETF
-
Cytokinetics Announces Data From Phase 1 Study of CK-4021586
-
Titan Announces Q&A Session with Shareholders
-
Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
-
Watsco to Present at the 12th Annual Morgan Stanley Laguna Conference on September 11, 2024 at 3:10 p.m. PDT
-
PlusInvesting Launches New Feature to Enhance Trading Efficiency for Canadian Users
-
Progress to Acquire ShareFile
-
NIP Group Inc. Enters Game Publishing Market, Expanding Digital Entertainment Ecosystem
-
FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
-
Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaen
-
Prelude Therapeutics Announces Publication of Abstract for Presentation at the European Society of Medical Oncology (ESMO) Congress 2024
-
Titan Announces Q&A Session with Shareholders
-
Theratechnologies to Present at Upcoming Investor Conferences in September
-
Data Center Developer and Operator Dataprana to Launch its First 30MW Immersion Site
-
PlusInvesting Launches New Feature to Enhance Trading Efficiency for Canadian Users
-
-
Half-year report 2024
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
New Data: Battery Thermal Runaway Incidents on Board Passenger and Cargo Aircraft Hit Record High as Passengers Remain Largely Unaware of Risks
-
Jiangsu-Germany Dialogue 2024 Held in Changzhou
-
Kraig Biocraft Laboratories Completes New Production Center, Expands Capacity more than Eightfold
-
Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
-
OraSure Technologies Elects Jack Kenny to the Board of Directors
-
Churchill Resources to Commence Drilling September 16 at Taylor Brook Magmatic Intrusive Complex; Large Tonnage Nickel Target added at Florence Lake
-
Mulvihill Capital Management Inc. Announces Ratios for Merger of Top 10 Split Trust into Premium Global Income Split Corp.
-
Marimaca Appoints Oscar Valenzuela as VP Project and Alexis Muñoz as VP Project Execution
-
Phillips Edison & Company Upgraded by Moody’s to ‘Baa2’ with Stable Outlook
-
Mobilicom Reports Financial Results for the Six Months Ended June 30, 2024; Revenues Up 232%
-
Phillips Edison & Company Upgraded by Moody’s to ‘Baa2’ with Stable Outlook
-
Regeneron to Highlight Progress Across Its Differentiated Oncology Portfolio and Pipeline at WCLC and ESMO
-
MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11
-
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
-
Coppernico Provides Drilling Update on the Sombrero Project and Announces Participation in Upcoming Fall Conferences
-
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
-
Freedom Holdings and The Awareness Group (TAG) Announce Binding LOI For Reverse Merger
-
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
-
Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta
-
Feed Ontario to release record-breaking food bank data on September 10, 2024
-
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to October 10, 2024
-
Roivant Provides Update on Graves’ Disease Development Program
